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A 35-year-old man presented to our unit in 2000 for
the investigation of asymptomatic proteinuria and
progressive renal dysfunction. Renal biopsy showed
that the renal tubules and vascular wall had scattered
cells with vacuolated and foamy cytoplasm, which were
positive for periodic acid–Schiff and periodic acid–
Schiff–methenamine stains (Panels A and B). Electron
microscopy demonstrated dense deposits in these
tubular epithelial cells, with some deposits acquiring
Panel B. Periodic acid–Schiff–methenamine stain shows silver
positive granules in the tubular epithelial cell cytoplasm.
Panel A. Light microscopy of swollen renal tubular cells, mainly
of the distal tubules, possessing fine foamy-appearing cytoplasm.
Panel C. Electron microscopy showing dense deposits in the
tubular epithelial cells. The deposits have the appearance of
lamellated membrane structures (myeloid bodies), which represent
the abnormal deposition of glycosphingolipids.
the appearance of “myelin” figures (Panel C). On
further questioning, our patient had experienced hand
numbness (acroparesthesia), heat intolerance and
hypohidrosis. There were also multiple skin angiokera-
tomas. Corneal keratopathy and subcapsular lenticular
opacities were shown on eye examination. Plasma
enzymatic assay confirmed -galactosidase deficiency
(0.3 nmol/mL.hr; reference: 8.8–14.5 nmol/mL.hr),
compatible with Fabry’s disease. His renal function
continued to deteriorate and reached end-stage renal
failure in December 2001.
Fabry’s disease is an X-linked recessive disease
caused by the partial or complete deficiency of -
galactosidase A, resulting in the abnormal accumulation
of glycosphingolipids in tissues. Renal involvement
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manifests early on as proteinuria, microscopic hema-
turia and chyluria, with progressive renal failure. The
diagnosis is made by a reduced blood -galactosidase
A activity or by performing pedigree-specific
mutational analysis. The current treatment of choice
for Fabry’s disease is enzyme replacement therapy
with recombinant human -galactosidase A, which
has been shown to successfully abrogate and reverse
the accumulation of glycosphingolipids in cells and
tissues.
